(UK)
Determining clinical categories & consensus definition of Atrial fibrillation burden
International consensus workshop 2023
This event is compliant with the MedTech Europe Code of Ethical Business Practice with reference number EMT29944.
Hilton Munich airport
View Location
RATIONALE & BACKGROUND
Atrial fibrillation (AF) is a major risk factor for stroke. Despite substantial advances in both the treatment for AF and the prevention of AF related strokes, fundamental questions on pathophysiological mechanisms, risk assessment, prevention and therapy are still unresolved. There is an unmet medical need for clinically applicable concepts in AF diagnostic workup and individual patient risk evaluation.
AIMS OF THE CONFERENCE
Primary Aims:
- Developing a consensus statement that defines the concept of AF burden as a clinically applicable principle to inform clinical evaluation in regard to diagnostic value, risk assessment and therapeutic options.
Secondary Aims:
- Addressing key questions that help to define the scope of AF burden,
- Developing a platform and structure for interdisciplinary expert discussion and consensus process for subsequent topics.
Scientific program nucleus
Meeting structure and concept outline
Co-Chairs
Nucleus
19 internationally renowned experts in AF and stroke prevention with high clinical and academic standing. A full time in-person attendance is required to ensure recognition of consensus voting (no late arrival or early departure).
FACULTY
OBSERVER
Industry partners with an interest in the topic will be invited:
- to observe the academic exchange
- to contribute to the debate in selected aspects
PROGRAM LOGISTICS
Two half days (afternoon – morning) with 2-3 sessions per half day, each addressing a specified topic (key question) in a defined structure:
- A kickstart presentation to introduce the topic and the unmet need (8 min max, invited presenter)
- Open discussion round the table (all)
- Presentation of the key question and options for a consensus (session chair)
- Discussion of the consensus options (all)
- Voting on a consensus for each question (all)
The final session will address the consensus statement on a clinical definition of AF burden.
- Impulse presentation to summarise the unmet need and the discussed key questions
- Propose a clinical definition of AF burden (session chair)
- Discussion and Voting for a consensus (all)
ORGANIZATION
Translational Medicine Academy (TMA)
Picasso Platz 8,
4052 Basel
Switzerland
CONTACTS
CHARLES SCHOEN – Operations Director
T. +33 (0) 608 18 77 08
Email : charles.schoen@tmacademy.org
FAB POLLER – Industry Relations
T. +33 (0)6 61 69 65 36
Email : fpoller@tmacademy.org
